Navigation Links
ADA releases updated position paper on vegetarian diets
Date:7/1/2009

CHICAGO The American Dietetic Association has released an updated position paper on vegetarian diets that concludes such diets, if well-planned, are healthful and nutritious for adults, infants, children and adolescents and can help prevent and treat chronic diseases including heart disease, cancer, obesity and diabetes.

ADA's position, published in the July issue of the Journal of the American Dietetic Association, represents the Association's official stance on vegetarian diets:

"It is the position of the American Dietetic Association that appropriately planned vegetarian diets, including total vegetarian or vegan diets, are healthful, nutritionally adequate and may provide health benefits in the prevention and treatment of certain diseases. Well-planned vegetarian diets are appropriate for individuals during all stages of the life-cycle including pregnancy, lactation, infancy, childhood and adolescence and for athletes."

ADA's position and accompanying paper were written by Winston Craig, PhD, MPH, RD, professor and chair of the department of nutrition and wellness at Andrews University; and Reed Mangels, PhD, RD, nutrition advisor at the Vegetarian Resource Group, Baltimore, Md.

The revised position paper incorporates new topics and additional information on key nutrients for vegetarians, vegetarian diets in the life cycle and the use of vegetarian diets in prevention and treatment of chronic diseases. "Vegetarian diets are appropriate for all stages of the life cycle," according to ADA's position. "There are many reasons for the rising interest in vegetarian diets. The number of vegetarians in the United States is expected to increase over the next decade."

Vegetarian diets are often associated with health advantages including lower blood cholesterol levels, lower risk of heart disease, lower blood pressure levels and lower risk of hypertension and type 2 diabetes, according to ADA's position. "Vegetarians te
'/>"/>

Contact: Jennifer STarkey
media@eatright.org
312-899-4802
American Dietetic Association
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Afghanistan releases its first-ever list of protected species
2. DOE JGI releases expanded version of Phytozome.net
3. ADA releases updated position statement on functional foods
4. Complete Genomics releases proof-of-concept data for its sequencing technology for the first time
5. The International Society for Stem Cell Research releases new guidelines
6. American Dietetic Association releases 2008 nutrition trends survey
7. SNM releases new fact sheet on breast cancer and molecular imaging
8. Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology
9. Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology
10. EPA releases report on climate change and health
11. EPA releases science assessment on health effects of nitrogen oxides
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... German ., Despite the fact that physical ... vary as to how space is encoded in their ... such as ,left, right, front, back, to talk about ... east, west, at all times for all scales: "The ... an snake by your Northern leg". Whether not only ...
(Date:12/15/2009)... an enormous emotional and economic toll on society. It ... currents each year in U.S. waters and it,s likely that ... A serious disconnect exists between rip current research and ... tides and undertows, and more importantly, most people do not ... rip current. , The goal of the Rip Current Symposium ...
(Date:12/14/2009)... 14, 2009) -- Researchers at Rice University and Baylor ... that can be tracked in real time with MRI ... with a fluorescent dye and kills them with heat. ... from a growing field called "theranostics" that develops technologies ... a single procedure. , The research is available online ...
Breaking Biology News(10 mins):More than a jump to the left 2Tracking new cancer-killing particles with MRI 2Photos 3A First of Its Kind Website Unveiled at Modern Moms Meet Modern Science Meeting 59728 1Photos 3A First of Its Kind Website Unveiled at Modern Moms Meet Modern Science Meeting 59728 2AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin 28AEZS 130 29 as First Oral Diagnostic Test for Growth Hormone Deficiency 14520 1AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin 28AEZS 130 29 as First Oral Diagnostic Test for Growth Hormone Deficiency 14520 2AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin 28AEZS 130 29 as First Oral Diagnostic Test for Growth Hormone Deficiency 14520 3Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 1Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 2Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 3Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 4Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 5
... by Princeton biologists has revealed a remarkably simple mechanism ... to travel in unison without any recognized leaders or ... 3 issue of Nature, helps settle age-old questions about ... for subtle signals or other explicit systems that animals ...
... with human immunodeficiency virus (HIV), highly active antiretroviral ... Kaposi sarcoma and non-Hodgkin lymphoma, according to a ... the Journal of the National Cancer Institute. , ... have reported increased risks of several cancers, including ...
... at the University of Pennsylvania School of Medicine have ... an Epstein-Barr Virus (EBV) protein known to be expressed ... a new mechanism by which EBV transforms human B ... can lead to development of B-cell lymphomas. , Erle ...
Other Biology News:Flocking together: Study shows how animal groups find their way 2Flocking together: Study shows how animal groups find their way 3Antiretroviral therapy may prevent excess risk of some cancers in people with HIV 2Epstein-Barr virus protein crucial to its role in blood cancers 2
(Date:12/15/2009)... WALTHAM, Mass., Dec. 15 Repligen Corporation ... Company has received $731,000 in research funding to ... Friedreich,s ataxia from the Muscular Dystrophy Association (MDA). ... preclinical GLP toxicology testing and GMP manufacture of ... Support from the MDA not only provides important ...
(Date:12/15/2009)... Medical, Inc. (OTC Bulletin Board : AEMD) announced ... Comper have joined the Science Advisory ... Schorey and Dr. Comper are leading researchers in ... of Aethlon Medical, was recently formed to leverage ... being advanced as an adjunct therapy for Hepatitis-C ...
(Date:12/15/2009)... 15 The Mosaic Company (NYSE: MOS ... 2010 earnings results and financial tables on Tuesday, January ... New York Stock Exchange. Results will be available ... Company will host a conference call with presentation slides ... The call will begin at 11:00 a.m. Eastern ...
(Date:12/15/2009)... MANOR, N.Y., Dec. 15 On January ... International Society for Medical Publication Professionals (ISMPP) will ... in London, UK. More than 100 attendees are ... forum for publication professionals, editors, publishers, medical writers ... of medical publications and the impact of guidelines ...
Breaking Biology Technology:Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2
... LEUVEN, Belgium, LUND, Sweden and BASEL, Switzerland, June ... AB (Nordic Exchange: BINV) announce that they have,entered ... for their jointly,developed anti-cancer agent TB-403. TB-403 is ... (PIGF), one of the growth factors,responsible for the ...
... Top 40, EAST HARTFORD, Conn., June 17 ... a new awards program in,partnership with accounting firm UHY ... companies in Connecticut. Companies will be,recognized on the basis ... revenue requirement of $50,000 and minimum revenues of $3 ...
... (Nasdaq: CADX ), a biopharmaceutical company focused ... use in the hospital setting, announced today that ... the corporate overview on,Monday, June 23, 2008 at ... Swann Pain Roundtable Conference at the Sofitel Hotel ...
Other Biology Technology:ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody 2ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody 3ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody 4ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody 5ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody 6Connecticut Technology Council to Recognize Fast Growing Technology Companies 2Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Leerink Swann Pain Roundtable Conference on June 23, 2008 in New York 2
General description: MaxiSorp TM surface is ideal for arraying molecules with mixed hydrophilic/hydrophobic domains such as proteins ID clarifier: Maxisorp(tm) with lid...
... for fully automated systems for a broad ... configured for applications ranging from compound logistics, ... loop screening, which means it has fully ... picking and follow up studies all at ...
... over 20 years of experience in providing ... Sciences, the Freedom EVO platform delivers even ... to future needs. Together with the new ... equipped to successfully operate genomics, proteomics, and ...
... Systems provide fast and reliable automation ... and drug development laboratories. Staccato Custom ... specifications, providing solutions that are tailored ... Custom Systems are controlled with either ...
Biology Products: